Chapter 4 : Infections with Multiple Hepatotropic Viruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Infections with Multiple Hepatotropic Viruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817947/9781555812447_Chap04-1.gif /docserver/preview/fulltext/10.1128/9781555817947/9781555812447_Chap04-2.gif


The hepatotropic viruses are a major public health problem representing the most common cause of liver disease worldwide. This chapter highlights the clinical, histologic, and virologic aspects of multiple hepatotropic viral infections. It emphasizes features differentiating these from single hepatotropic infections and the mechanisms of viral interactions. Furthermore, the efficacy and limitations of current treatment options are discussed in addition to future treatment approaches. Finally, the chapter reviews the important interaction between the hepatotropic viruses and human immunodeficiency virus (HIV), not a hepatotropic virus per se, but frequently encountered in patients with parenteral exposures because of common routes of transmission.

Citation: Myers R, Ratziu V, Benhamou Y, Di Martino V, Moussalli J, Hélène Tainturier M, Poynard T. 2002. Infections with Multiple Hepatotropic Viruses, p 51-74. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch4

Key Concept Ranking

Tumor Necrosis Factor alpha
Highly Active Antiretroviral Therapy
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Allory, Y.,, F. Charlotte,, Y. Benhamou,, P. Opolon,, Y. Le Charpentier,, T. Poynard, and the MULTIVIRC Group. 2000. Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a casecontrol study. Hum. Pathol. 31:6974.
2. Alter, H. J. 1996. The cloning and clinical implications of HGV and HGBV-C. N. Engl. J. Med. 334:15361537.
3. Alter, H. J.,, Y. Nakatsuji,, J. Melpolder,, J. Wages,, R. Wesley,, J. W. Shih,, and J. P. Kim. 1997. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N. Engl. J. Med. 336:747754.
4.Anonymous. 1997. Management of hepatitis C: NIH Consensus Statement. Hepatology 15:141.
5.Anonymous. 1999. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 48:137.
6. Balik, I.,, M. Onul,, E. Tekeli,, and F. Caredda. 1991. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey. Eur. J. Epidemiol. 7:4854.
7. Barzilai, A.,, S. Schulman,, Y. V. Karetnyi,, M. O. Favorov,, E. Levin,, E. Mendelson,, P. Weiss,, H. A. Fields,, D. Varon,, and U. Martinowitz. 1995. Hepatitis E virus infection in hemophiliacs. J. Med. Virol. 46:153156.
8. Beld, M.,, M. Penning,, V. Lukashov,, M. McMorrow,, M. Roos,, N. Pakker,, A. van den Hoek,, and J. Goudsmit. 1998. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 244:504512.
9. Benhamou, Y.,, M. Bochet,, V. Di Martino,, F. Charlotte,, F. Azria,, A. Coutellier,, M. Vidaud,, F. Bricaire,, P. Opolon,, C. Katlama,, T. Poynard, and the Multivirc Group. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30:10541058.
10. Benhamou, Y.,, M. Bochet,, V. Thibault,, V. Di Martino,, E. Caumes,, F. Bricaire,, P. Opolon,, C. Katlama,, and T. Poynard. 1999. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 30:13021306.
11. Benhamou, Y.,, M. Bochet,, V. Thibault,, V. Calvez,, M. H. Fievet,, C. Brosgart,, J. Fry,, C. S. Gibbs,, P. Opolon,, and T. Poynard. 2001. An open-label pilot study of adefovir dipivoxil in HIV/HBV co-infected patients with lamivudine resistant HBV. Lancet 358:718723.
12. Benhamou, Y.,, V. Di Martino,, M. Bochet,, G. Colombet,, V. Thibault,, A. Liou,, C. Katlama,, and T. Poynard. 2001. Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy. Hepatology 34:283287.
13. Benvegnu, L.,, G. Fattovich,, F. Noventa,, F. Tremolada,, L. Chemello,, A. Cecchetto,, and A. Alberti. 1994. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74:24422448.
14.. Benvegnu, L.,, F. Noventa,, E. Bernardinello,, P. Pontisso,, A. Gatta,, and A. Alberti. 2001. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut 48:110115.
15. Berenguer, M.,, N. A. Terrault,, M. Piatak,, A. Yun,, J. P. Kim,, J. Y. Lau,, J. R. Lake,, J. R. Roberts,, N. L. Ascher,, L. Ferrell,, and T. L. Wright. 1996. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 111:15691575.
16. Blumberg, B. S.,, B. J. Gerstley,, D. A. Hungerford,, W. T. London,, and A. I. Sutnick. 1967. A serum antigen (Australia antigen) in Down’s syndrome, leukemia, and hepatitis. Ann. Intern. Med. 66:924931.
17. Bodsworth, N.,, B. Donovan,, and B. N. Nightingale. 1989. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J. Infect. Dis. 160:577582.
18. Bodsworth, N. J.,, D. A. Cooper,, and B. Donovan. 1991. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J. Infect. Dis. 163:11381140.
19. Bonino, F.,, F. Oliveri,, P. Colombatto,, and M. R. Brunetto. 1997. Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: results of an international survey. J. Viral. Hepat. 4:7982.
20. Boyer, N.,, P. Marcellin,, C. Degott,, F. Degos,, A. G. Saimot,, S. Erlinger,, J. P. Benhamou, and the Comité des Anti-Viraux. 1992. Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. J. Infect. Dis. 165:723726.
21. Bradley, D. W.,, J. E. Maynard,, K. A. Mc- Caustland,, B. L. Murphy,, E. H. Cook,, and J. W. Ebert. 1983. Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections. J. Med. Virol. 11:207213.
22. Brandhagen, D. J.,, J. B. Gross, Jr.,, J. J. Poterucha,, M. R. Charlton,, J. Detmer,, J. Kolberg,, A. A. Gossard,, K. P. Batts,, W. R. Kim,, J. J. Germer,, R. H. Wiesner,, and D. H. Persing. 1999. The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C. Am. J. Gastroenterol. 94:10001005.
23. Brotman, B.,, A. M. Prince,, T. Huima,, L. Richardson,, M. C. van den Ende,, and U. Pfeifer. 1983. Interference between non-A, non- B and hepatitis B virus infection in chimpanzees. J. Med. Virol. 11:191205.
24. Caredda, F.,, S. Antinori,, C. Pastecchia,, P. Coppin,, M. Palla,, A. Ponzetto,, M. Rizzetto,, and M. Moroni. 1989. Incidence of hepatitis delta virus infection in acute HBsAgnegative hepatitis. J. Infect. Dis. 159:977979.
25. Carr, A.,, and D. A. Cooper. 1997. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet 349:995996.
26. Chan, H. L.,, M. G. Ghany,, and A. S. F. Lok,. 1999. Hepatitis B. In E. R. Schiff,, M. F. Sorrell,, and W. C. Maddrey (ed.), Schiff’s Diseases of the Liver, 8th ed. [CD-ROM.] Lippincott Williams & Wilkins Publishers, Philadelphia, Pa.
27. Chang, M. H.,, C. J. Chen,, M. S. Lai,, H. M. Hsu,, T. C. Wu,, M. S. Kong,, D. C. Liang,, W. Y. Shau,, D. S. Chen, and the Taiwan Childhood Hepatoma Study Group. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 336:18551859.
28. Charlton, M. R.,, D. Brandhagen,, R. H. Wiesner,, J. B. Gross, Jr.,, J. Detmer,, M. Collins,, J. Kolberg,, R. A. Krom,, and D. H. Persing. 1998. Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring? Transplantation 65:7376.
29. Choo, Q. L.,, G. Kuo,, A. J. Weiner,, L. R. Overby,, D. W. Bradley,, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359362.
30. Colin, J. F.,, D. Cazals-Hatem,, M. A. Loriot,, M. Martinot-Peignoux,, B. N. Pham,, A. Auperin,, C. Degott,, J. P. Benhamou,, S. Erlinger,, D. Valla,, and P. Marcellin. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29:13061310.
31. Crespo, J.,, J. L. Lozano,, F. de la Cruz,, L. Rodrigo,, M. Rodriguez,, G. San Miguel,, E. Artinano,, and F. Pons-Romero. 1994. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am. J. Gastroenterol. 89:11471151.
32. Daar, E. S.,, H. Lynn,, S. Donfield,, E. Gomperts,, M. W. Hilgartner,, W. K. Hoots,, D. Chernoff,, S. Arkin,, W. Y. Wong,, and C. A. Winkler. 2001. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J. Acquir. Immune Defic. Syndr. 26:466472.
33. Darby, S. C.,, D. W. Ewart,, P. L. Giangrande,, R. J. Spooner,, C. R. Rizza,, G. M. Dusheiko,, C. A. Lee,, C. A. Ludlam,, and F. E. Preston for the UK Haemophilia Centre Directors’ Organisation. 1997. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 350:14251431.
34. Doo, E. C.,, and J. T. Liang,. 1999. The hepatitis viruses. In E. R. Schiff,, M. F. Sorrell,, and W. C. Maddrey (ed.), Schiff’s Diseases of the Liver, 8th ed. [CD-ROM.] Lippincott Williams & Wilkins Publishers, Philadelphia, Pa.
35. Fattovich, G.,, S. Boscaro,, F. Noventa,, E. Pornaro,, D. Stenico,, A. Alberti,, A. Ruol,, and G. Realdi. 1987. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J. Infect. Dis. 155:931935.
36. Fattovich, G.,, L. Brollo,, G. Giustina,, F. Noventa,, P. Pontisso,, A. Alberti,, G. Realdi,, and A. Ruol. 1991. Natural history and prognostic factors for chronic hepatitis type B. Gut 32:294298.
37. Fattovich, G.,, M. L. Ribero,, S. Favarato,, F. Azzario,, F. Donato,, G. Giustina,, M. Fasola,, M. Pantalena,, G. Portera,, and A. Tagger. 1998. Influence of GB virus-C/hepatitis G virus infection on the long-term course of chronic hepatitis B. Liver 18:360365.
38. Fattovich, G.,, G. Giustina,, E. Christensen,, M. Pantalena,, I. Zagni,, G. Realdi,, and S. W. Schalm for the European Concerted Action on Viral Hepatitis (Eurohep). 2000. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut 46:420426.
39. Feray, C.,, M. Gigou,, D. Samuel,, G. Reyes,, J. Bernuau,, M. Reynes,, H. Bismuth,, and C. Brechot. 1993. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 104:549555.
40. Fong, T. L.,, A. M. Di Bisceglie,, J. G. Waggoner,, S. M. Banks,, and J. H. Hoofnagle. 1991. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 14:6467.
41. Gaeta, G. B.,, T. Stroffolini,, M. Chiaramonte,, T. Ascione,, G. Stornaiuolo,, S. Lobello,, E. Sagnelli,, M. R. Brunetto,, and M. Rizzetto. 2000. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 32:824827.
42.. Garcia-Samaniego, J.,, V. Soriano,, J. Castilla,, R. Bravo,, A. Moreno,, J. Carbo,, A. Iniguez,, J. Gonzalez,, F. Munoz, and the Hepatitis/HIV Spanish Study Group. 1997. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Am. J. Gastroenterol. 92:11301134.
43. Ghany, M. G.,, C. Leissinger,, R. Lagier,, R. Sanchez-Pescador,, and A. S. Lok. 1996. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig. Dis. Sci. 41:12651272.
44. Gilles, P. N.,, G. Fey,, and F. V. Chisari. 1992. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:39553960.
45. Gilson, R. J.,, A. E. Hawkins,, M. R. Beecham,, E. Ross,, J. Waite,, M. Briggs,, T. McNally,, G. E. Kelly,, R. S. Tedder,, and I. V. Weller. 1997. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 11:597606.
46. Glue, P.,, R. Rouzier-Panis,, C. Raffanel,, R. Sabo,, S. K. Gupta,, M. Salfi,, S. Jacobs,, R. P. Clement, and the Hepatitis C Intervention Therapy Group. 2000. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. Hepatology 32:647653.
47. Graham, C. S.,, L. R. Baden,, E. Yu,, J. M. Mrus,, J. Carnie,, T. Heeren,, and M. J. Koziel. 2001. Influence of human immunodeficiency virus infection on the course of hepatitis c virus infection: a meta-analysis. Clin. Infect. Dis. 33:562569.
48. Greub, G.,, B. Ledergerber,, M. Battegay,, P. Grob,, L. Perrin,, H. Furrer,, P. Burgisser,, P. Erb,, K. Bogglan,, J. C. Piffaretti,, B. Hirschel,, P. Janin,, P. Francioli,, M. Flepp,, and A. Telenti. 2000. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356:18001805.
49. Grinde, B.,, K. Stene-Johansen,, B. Sharma,, T. Hoel,, M. Jensenius,, and K. Skaug. 1997. Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers—infection by needle sharing? J. Med. Virol. 53:6975.
50. Guptan, R. C.,, V. Thakur,, V. Raina,, and S. K. Sarin. 1999. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J. Gastroenterol. Hepatol. 14:893898.
51. Helbling, B.,, R. Kammerlander,, and E. L. Renner. 1998. Acute hepatitis A (AHA) in patients with chronic hepatitis C (CHC): no increased case-fatality rate. Hepatology 28:276A. (Abstract.)
52. Hoggard, P. G.,, S. Kewn,, M. G. Barry,, S. H. Khoo,, and D. J. Back. 1997. Effects of drugs on 2′,3′-dideoxy-2′,3′-didehydrothymidine phosphorylation in vitro. Antimicrob. Agents Chemother. 41:12311236.
53. Hollinger, F. B.,, G. Dolana,, W. Thomas,, and F. Gyorkey. 1984. Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate. J. Infect. Dis. 150:250262.
54. Housset, C.,, E. Lamas,, V. Courgnaud,, O. Boucher,, P. M. Girard,, C. Marche,, and C. Brechot. 1993. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. J. Hepatol. 19:252258.
55. Japour, A. J.,, J. J. Lertora,, P. M. Meehan,, A. Erice,, J. D. Connor,, B. P. Griffith,, P. A. Clax,, J. Holden-Wiltse,, S. Hussey,, M. Walesky,, E. Cooney,, R. Pollard,, J. Timpone,, C. McLaren,, N. Johanneson,, K. Wood,, D. Booth,, Y. Bassiakos,, and C. S. Crumpacker. 1996. A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:235246.
56. Jardi, R.,, F. Rodriguez,, M. Buti,, X. Costa,, M. Cotrina,, R. Galimany,, R. Esteban,, and J. Guardia. 2001. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34:404410.
57. Kao, J. H.,, C. J. Liu,, P. J. Chen,, W. Chen,, S. C. Hsiang,, M. Y. Lai,, and D. S. Chen. 1997. Interspousal transmission of GB virus- C/hepatitis G virus: a comparison with hepatitis C virus. J. Med. Virol. 53:348353.
58. Keeffe, E. B. 1995. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am. J. Gastroenterol. 90:201205.
59. Keeffe, E. B.,, S. Iwarson,, B. J. McMahon,, K. L. Lindsay,, R. S. Koff,, M. Manns,, R. Baumgarten,, M. Wiese,, M. Fourneau,, A. Safary,, R. Clemens,, and D. S. Krause. 1998. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 27:881886.
60. Kew, M. C.,, M. C. Yu,, M. A. Kedda,, A. Coppin,, A. Sarkin,, and J. Hodkinson. 1997. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 112:184187.
61. Koff, R. S. 1992. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 10:S15S17.
62. Koike, K.,, K. Yasuda,, H. Yotsuyanagi,, K. Moriya,, K. Hino,, K. Kurokawa,, and S. Iino. 1995. Dominant replication of either virus in dual infection with hepatitis viruses B and C. J. Med. Virol. 45:236239.
63. Krogsgaard, K.,, B. O. Lindhardt,, J. O. Nielson,, P. Andersson,, P. Kryger,, J. Aldershvile,, J. Gerstoft,, and C. Pedersen. 1987. The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 7:3741.
64. Kuo, G.,, Q. L. Choo,, H. J. Alter,, G. L. Gitnick,, A. G. Redeker,, R. H. Purcell,, T. Miyamura,, J. L. Dienstag,, M. J. Alter,, C. E. Stevens, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non- A, non-B hepatitis. Science 244:362364.
65. Landau, A.,, D. Batisse,, J. P. Van Huyen,, C. Piketty,, F. Bloch,, G. Pialoux,, L. Belec,, J. P. Petite,, L. Weiss,, and M. D. Kazatchkine. 2000. Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients. AIDS 14:839844.
66. Lau, D. T.,, D. E. Kleiner,, Y. Park,, A. M. Di Bisceglie,, and J. H. Hoofnagle. 1999. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 117:12291233.
67. Lau, J. Y.,, K. Qian,, J. Detmer,, M. L. Collins,, E. Orito,, J. A. Kolberg,, M. S. Urdea,, M. Mizokami,, and G. L. Davis. 1997. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBVC/ HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. J. Infect. Dis. 176:421426.
68. Lauer, G. M.,, and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:4152.
69. Lechmann, M.,, and T. J. Liang. 2000. Vaccine development for hepatitis C. Semin. Liver Dis. 20:211226.
70. Leung, N. W.,, C. L. Lai,, T. T. Chang,, R. Guan,, C. M. Lee,, K. Y. Ng,, S. G. Lim,, P. C. Wu,, J. C. Dent,, S. Edmundson,, L. D. Condreay,, and R. N. Chien. 2001. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33:15271532.
71. Liaw, Y. F.,, S. L. Tsai,, J. J. Chang,, I. S. Sheen,, R. N. Chien,, D. Y. Lin,, and C. M. Chu. 1994. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 106:10481053.
72. Liaw, Y. F. 1995. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22:11011108.
73. Liaw, Y. F.,, S. L. Tsai,, I. S. Sheen,, M. Chao,, C. T. Yeh,, S. Y. Hsieh,, and C. M. Chu. 1998. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am. J. Gastroenterol. 93: 354359.
74. Lightfoot, K.,, M. Skelton,, M. C. Kew,, M. C. Yu,, M. A. Kedda,, A. Coppin,, and J. Hodkinson. 1997. Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans? Hepatology 26:740742.
75. Linnen, J.,, J. Wages, Jr.,, Z. Y. Zhang-Keck,, K. E. Fry,, K. Z. Krawczynski,, H. Alter,, E. Koonin,, M. Gallagher,, M. Alter,, S. Hadziyannis,, P. Karayiannis,, K. Fung,, Y. Nakatsuji,, J. W. Shih,, L. Young,, M. Piatak, Jr.,, C. Hoover,, J. Fernandez,, S. Chen,, J. C. Zou,, T. Morris,, K. C. Hyams,, S. Ismay,, J. D. Lifson,, J. P. Kim, et al. 1996. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505508.
76. Lok, A. S.,, E. J. Heathcote,, and J. H. Hoofnagle. 2001. Management of hepatitis B: 2000— summary of a workshop. Gastroenterology 120:18281853.
77. Malaguarnera, M.,, S. Restuccia,, G. Pistone,, P. Ruello,, I. Giugno,, and B. A. Trovato. 1996. A meta-analysis of interferon-alpha treatment of hepatitis D virus infection. Pharmacotherapy 16:609614.
78. Marcellin, P.,, N. Boyer,, J. F. Colin,, M. Martinot-Peignoux,, V. Lefort,, S. Matheron,, S. Erlinger,, and J. P. Benhamou. 1993. Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine. Gut 34:S106.
79. Marriott, E.,, S. Navas,, J. del Romero,, S. Garcia,, I. Castillo,, J. A. Quiroga,, and V. Carreno. 1993. Treatment with recombinant alpha- interferon of chronic hepatitis C in anti- HIV-positive patients. J. Med. Virol. 40:107111.
80. Mast, E. E.,, F. J. Mahoney,, M. J. Alter,, and H. S. Margolis. 1998. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine 16(Suppl.):S48S51.
81. Mathurin, P.,, V. Thibault,, K. Kadidja,, N. Ganne-Carrie,, J. Moussalli,, M. El Younsi,, V. Di Martino,, F. Lunel,, F. Charlotte,, M. Vidaud,, P. Opolon,, and T. Poynard. 2000. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J. Viral Hepat. 7:1522.
82. Matsiota-Bernard, P.,, G. Vrioni,, C. Onody,, L. Bernard,, P. de Truchis,, and C. Peronne. 2001. Human immunodeficiency virus (HIV) protease inhibitors have no effect on hepatitis C virus (HCV) serum levels of HIV-HCV co-infected patients. Int. J. Antimicrob. Agents 17:155157.
83. Matthews-Greer, J. M.,, G. C. Caldito,, S. D. Adley,, R. Willis,, A. C. Mire,, R. M. Jamison,, K. L. McRae,, J. W. King,, and W. L. Chang. 2001. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 8:690694.
84. Mauss, S.,, H. Klinker,, A. Ulmer,, R. Willers,, B. Weissbrich,, H. Albrecht,, D. Haussinger,, and H. Jablonowski. 1998. Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count. Infection 26:1619.
85. McDonald, J. A.,, L. Caruso,, P. Karayiannis,, L. J. Scully,, J. R. Harris,, G. E. Forster,, and H. C. Thomas. 1987. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon. Hepatology 7:719723.
86. McHutchison, J. G.,, O. V. Nainan,, M. J. Alter,, A. Sedghi-Vaziri,, J. Detmer,, M. Collins,, and J. Kolberg. 1997. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA. Hepatology 26:13221327.
87. McHutchison, J. G.,, S. C. Gordon,, E. R. Schiff,, M. L. Shiffman,, W. M. Lee,, V. K. Rustgi,, Z. D. Goodman,, M. H. Ling,, S. Cort,, J. K. Albrecht, and the Hepatitis Interventional Therapy Group. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:14851492.
88. Mimms, L. T.,, J. W. Mosley,, F. B. Hollinger,, R. D. Aach,, C. E. Stevens,, M. Cunningham,, D. V. Vallari,, L. H. Barbosa,, and G. J. Nemo. 1993. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 307:10951097.
89. Monga, H. K.,, M. C. Rodriguez-Barradas,, K. Breaux,, K. Khattak,, C. L. Troisi,, M. Velez,, and B. Yoffe. 2001. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin. Infect. Dis. 33:240247.
90. Murphy, E. L.,, A. C. Collier,, L. A. Kalish,, S. F. Assmann,, M. F. Para,, T. P. Flanigan,, P. N. Kumar,, L. Mintz,, F. R. Wallach,, and G. J. Nemo. 2001. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann. Intern. Med. 135:1726.
91. Myers, R. P.,, J. C. Gregor,, and P. J. Marotta. 2000. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 31:834839.
92. Piroth, L.,, M. Duong,, C. Quantin,, M. Abrahamowicz,, R. Michardiere,, L. S. Aho,, M. Grappin,, M. Buisson,, A. Waldner,, H. Portier,, and P. Chavanet. 1998. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 12:381388.
93. Pontisso, P.,, M. G. Ruvoletto,, G. Fattovich,, L. Chemello,, A. Gallorini,, A. Ruol,, and A. Alberti. 1993. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105:15291533.
94. Pontisso, P.,, M. Gerotto,, M. G. Ruvoletto,, G. Fattovich,, L. Chemello,, S. Tisminetzky,, F. Baralle,, and A. Alberti. 1996. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J. Med. Virol. 48:157160.
95. Pontisso, P.,, M. Gerotto,, L. Benvegnu,, L. Chemello,, and A. Alberti. 1998. Coinfection by hepatitis B virus and hepatitis C virus. Antivir. Ther. 3:137142.
96. Poynard, T.,, P. Bedossa,, and P. Opolon. 1997. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825832.
97. Poynard, T.,, P. Marcellin,, S. S. Lee,, C. Niederau,, G. S. Minuk,, G. Ideo,, V. Bain,, J. Heathcote,, S. Zeuzem,, C. Trepo,, J. Albrecht, and the International Hepatitis Interventional Therapy Group (IHIT). 1998. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 352:14261432.
98. Poynard, T.,, V. Ratziu,, Y. Benhamou,, P. Opolon,, P. Cacoub,, and P. Bedossa. 2000. Natural history of HCV infection. Bailliere’s Best Pract. Res. Clin. Gastroenterol. 14:211228.
99. Poynard, T.,, V. Ratziu,, F. Charlotte,, Z. Goodman,, J. McHutchison,, and J. Albrecht. 2001. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J. Hepatol. 34:730739.
100. Rizzetto, M.,, G. Verme,, S. Recchia,, F. Bonino,, P. Farci,, S. Arico,, R. Calzia,, A. Picciotto,, M. Colombo,, and H. Popper. 1983. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann. Intern. Med. 98:437441.
101. Rizzetto, M.,, and A. Smedile,. 1999. Hepatitis D. In E. R. Schiff,, M. F. Sorrell,, and W. C. Maddrey (ed.), Schiff’s Diseases of the Liver, 8th ed. [CD-ROM.] Lippincott Williams & Wilkins Publishers, Philadelphia, Pa.
102. Rodriguez-Mendez, M. L.,, A. Gonzalez- Quintela,, A. Aguilera,, and E. Barrio. 2000. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am. J. Gastroenterol. 95:13161322.
103. Rosina, F.,, and M. Rizzetto. 1989. Treatment of chronic type D (delta) hepatitis with alpha interferon. Semin. Liver Dis. 9:264266.
104.. Sagnelli, E.,, N. Coppola,, C. Scolastico,, P. Filippini,, T. Santantonio,, T. Stroffolini,, and F. Piccinino. 2000. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 32:11061110.
105. Saillour, F.,, F. Dabis,, M. Dupon,, D. Lacoste,, P. Trimoulet,, P. Rispal ,. E. Monlun,, J. M. Ragnaud,, P. Morlat,, J. L. Pellegrin,, H. Fleury,, P. Couzigou, and the Groupe d’Épidémiologie Clinique du SIDA. 1996. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Br. Med. J. 313:461464.
106. Saracco, G.,, F. Rosina,, M. R. Brunetto,, P. Amoroso,, F. Caredda,, P. Farci,, P. Piantino,, F. Bonino,, and M. Rizzetto. 1987. Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. J. Hepatol. 5:274281.
107. Sato, S.,, S. Fujiyama,, M. Tanaka,, K. Yamasaki,, I. Kuramoto,, S. Kawano,, T. Sato,, K. Mizuno,, and S. Nonaka. 1994. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J. Hepatol. 21:159166.
108. Scoazec, J. Y.,, and G. Feldmann. 1990. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology 12:505510.
109. Seeff, L. B.,, Z. Buskell-Bales,, E. C. Wright,, S. J. Durako,, H. J. Alter,, F. L. Iber,, F. B. Hollinger,, G. Gitnick,, R. G. Knodell,, R. P. Perrillo, and the National Heart, Lung, and Blood Institute Study Group. 1992. Long-term mortality after transfusion- associated non-A, non-B hepatitis. N. Engl. J. Med. 327:19061911.
110. Seeff, L. B.,, R. N. Miller,, C. S. Rabkin,, Z. Buskell-Bales,, K. D. Straley-Eason,, B. L. Smoak,, L. D. Johnson,, S. R. Lee,, and E. L. Kaplan. 2000. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann. Intern. Med. 132:105111.
111. Sheen, I. S.,, Y. F. Liaw,, D. Y. Lin,, and C. M. Chu. 1994. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J. Infect. Dis. 170:358361.
112. Sherman, M., for the CASL Hepatitis Consensus Group, Canadian Association for Study of the Liver. 1997. Management of viral hepatitis: clinical and public health perspectives— a consensus statement. Can. J. Gastroenterol. 11:407416.
113. Shih, C. M.,, S. J. Lo,, T. Miyamura,, S. Y. Chen,, and Y. H. Lee. 1993. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67:58235832.
114. Sinicco, A.,, R. Ralteri,, M. Sciandra,, C. Bertone,, A. Lingua,, B. Salassa,, and P. Gioannini. 1997. Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus: no evidence of faster progression to AIDS. Scand. J. Infect. Dis. 29:111115.
115. Slimane, S. B.,, J. K. Albrecht,, J. W. Fang,, Z. Goodman,, M. Mizokami,, K. Qian,, and J. Y. Lau. 2000. Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients. J. Viral Hepat. 7:5155.
116. Soriano, V.,, R. Bravo,, J. G. Samaniego,, J. Gonzalez,, P. M. Odriozola,, E. Arroyo,, J. L. Vicario,, A. Castro,, M. Colmenero,, E. Carballo, and the HIV-Hepatitis Spanish Study Group. 1994. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. AIDS 8:16211622.
117. Soriano, V.,, J. Garcia-Samaniego,, R. Bravo,, J. Gonzalez,, A. Castro,, J. Castilla,, P. Martinez-Odriozola,, M. Colmenero,, E. Carballo,, D. Suarez,, F. J. Rodriguez- Pinero,, A. Moreno,, J. del Romero,, J. Pedreira,, J. Gonzalez-Lahoz, and the Hepatitis- HIV Spanish Study Group. 1996. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 23:585591.
118. Soriano, V.,, J. Garcia-Samaniego,, R. Bravo,, J. Gonzalez,, A. Castro,, P. Martnez- Odriozola,, M. Colmenero,, E. Carballo,, D. Suarez,, J. Castilla,, F. J. Rodriguez-Pinero,, A. Moreno,, J. del Romero,, J. Pedreira,, J. Gonzalez-Lahoz, and the Spanish Group for the Study of Viral Hepatitis in HIV+ Patients. 1986. The treatment of chronic hepatitis C with interferon in patients infected with the human immunodeficiency virus. Med. Clin. (Barcelona) 106:486490. (In Spanish.)
119. Soriano, V.,, R. Bravo,, J. Garcia- Samaniego,, J. Castilla,, J. Gonzalez,, A. Castro,, J. M. Llibre, and the Hepatitis/HIV Spanish Study Group. 1997. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. AIDS 11:400401.
120. Soriano, V.,, J. Garcia-Samaniego,, R. Rodriguez- Rosado,, J. Gonzalez,, and J. Pedreira. 1999. Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. J. Hepatol. 31:119123.
121. Soriano, V.,, J. Garcia-Samaniego,, E. Valencia,, R. Rodriguez-Rosado,, F. Munoz,, and J. Gonzalez-Lahoz. 1999. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur. J. Epidemiol. 15:14.
122. Soriano, V.,, R. Rodriguez-Rosado,, and J. Garcia-Samaniego. 1999. Management of chronic hepatitis C in HIV-infected patients. AIDS 13:539546.
123. Soto, B.,, A. Sanchez-Quijano,, L. Rodrigo,, J. A. del Olmo,, M. Garcia-Bengoechea,, J. Hernandez-Quero,, C. Rey,, M. A. Abad,, M. Rodriguez,, M. Sales Gilabert,, F. Gonzalez,, P. Miron,, A. Caruz,, F. Relimpio,, R. Torronteras,, M. Leal,, and E. Lissen. 1997. Human immunodeficiency virus infection modifies the natural history of chronic parenterally- acquired hepatitis C with an unusually rapid progression to cirrhosis. J. Hepatol. 26:15.
124. Tanaka, E.,, H. J. Alter,, Y. Nakatsuji,, J. W. Shih,, J. P. Kim,, A. Matsumoto,, M. Kobayashi,, and K. Kiyosawa. 1996. Effect of hepatitis G virus infection on chronic hepatitis C. Ann. Intern. Med. 125:740743.
125. Taniguchi, M.,, A. O. Shakil,, H. E. Vargas,, T. Laskus,, A. J. Demetris,, T. Gayowski,, S. F. Dodson,, J. J. Fung,, and J. Rakela. 2000. Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D. Liver Transplant. 6:9296.
126. Telfer, P.,, C. Sabin,, H. Devereux,, F. Scott,, G. Dusheiko,, and C. Lee. 1994. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br. J. Haematol. 87:555561.
127. Telfer, P. T.,, D. Brown,, H. Devereux,, C. A. Lee,, and G. M. DuSheiko. 1994. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients. Br. J. Haematol. 88:397399.
128. Terrault, N. A. 2000. Hepatitis C virus and liver transplantation. Semin. Gastrointest. Dis. 11: 96114.
129. Thevenot, T.,, V. Di Martino,, J. F. Colin,, F. Degos,, S. Erlinger,, J. P. Benhamou,, and P. Marcellin. 1998. Detrimental influence of HIV on the natural history and the interferon response rate in patients with chronic hepatitis B. Gastroenterology 114:A1354. (Abstract.)
130. Thevenot, T.,, C. Regimbeau,, V. Ratziu,, V. Leroy,, P. Opolon,, and T. Poynard. 2001. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update. J. Viral Hepat. 8:4862.
131. Tsai, S. L.,, Y. F. Liaw,, C. T. Yeh,, C. M. Chu,, and G. C. Kuo. 1995. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology 21:908912.
132. Tsiquaye, K. N.,, B. Portmann,, G. Tovey,, H. Kessler,, S. Hu,, X. Z. Lu,, A. J. Zuckerman,, J. Craske,, and R. Williams. 1983. Non-A, non-B hepatitis in persistent carriers of hepatitis B virus. J. Med. Virol. 11:179189.
133. Vento, S.,, T. Garofano,, C. Renzini,, F. Cainelli,, F. Casali,, G. Ghironzi,, T. Ferraro,, and E. Concia. 1998. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N. Engl. J. Med. 338:286290.
134. Viazov, S.,, M. Riffelmann,, S. Sarr,, A. Ballauff,, H. Meisel,, and M. Roggendorf. 1997. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J. Hepatol. 27:8590.
135. Villa, E.,, A. Grottola,, P. Trande,, Y. Selum,, A. M. Rebecchi,, A. Dugani,, and F. Manenti. 1993. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients. Lancet 341:1413.
136. Villa, E.,, A. Grottola,, P. Buttafoco,, P. Trande,, A. Merighi,, N. Fratti,, Y. Seium,, G. Cioni,, and F. Manenti. 1995. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B. Dig. Dis. Sci. 40:813.
137. Weltman, M. D.,, A. Brotodihardjo,, E. B. Crewe,, G. C. Farrell,, M. Bilous,, J. M. Grierson,, and C. Liddle. 1995. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J. Viral. Hepat. 2:3945.
138. Wolters, L. M.,, A. B. van Nunen,, P. Honkoop,, A. C. Vossen,, H. G. Niesters,, P. E. Zondervan,, and R. A. de Man. 2000. Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J. Viral. Hepat. 7:428434.
139. Wong, D. K.,, C. Yim,, C. D. Naylor,, E. Chen,, M. Sherman,, S. Vas,, I. R. Wanless,, S. Read,, H. Li,, and E. J. Heathcote. 1995. Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population. Gastroenterology 108:165171.
140. Wu, J. C.,, C. L. Chen,, M. C. Hou,, T. Z. Chen,, S. D. Lee,, and K. J. Lo. 1994. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology 19:836840.
141. Wu, J. C.,, T. Z. Chen,, Y. S. Huang,, F. S. Yen,, L. T. Ting,, W. Y. Sheng,, S. H. Tsay,, and S. D. Lee. 1995. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology 108:796802.
142. Yap, S. H.,, J. A. Hellings,, P. J. Rijntjes,, A. M. van Loon,, W. Duermeyer,, and R. Stute. 1985. Absence of detectable hepatitis B virus DNA in sera and liver of chimpanzees with non-A, non-B hepatitis. J. Med. Virol. 15:343350.
143. Yeh, C. T.,, C. T. Chiu,, S. L. Tsai,, S. T. Hong,, C. M. Chu,, and Y. F. Liaw. 1994. Absence of precore stop mutant in chronic dual (B and C) and triple (B, C, and D) hepatitis virus infection. J. Infect. Dis. 170:15821585.
144. Yu, M. C.,, M. J. Tong,, P. Coursaget,, R. K. Ross,, S. Govindarajan,, and B. E. Henderson. 1990. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J. Natl. Cancer Inst. 82:10381041.
145. Zarski, J. P.,, B. Bohn,, A. Bastie,, J. M. Pawlotsky,, M. Baud,, F. Bost-Bezeaux,, J. Tran van Nhieu,, J. M. Seigneurin,, C. Buffet,, and D. Dhumeaux. 1998. Characteristics of patients with dual infection by hepatitis B and C viruses. J. Hepatol. 28:2733.
146. Zeuzem, S.,, S. V. Feinman,, J. Rasenack,, E. J. Heathcote,, M. Y. Lai,, E. Gane,, J. O’- Grady,, J. Reichen,, M. Diago,, A. Lin,, J. Hoffman,, and M. J. Brunda. 2000. Peginterferon alfa-2a in patients with chronic hepatitis C. N. Engl. J. Med. 343:16661672.
147. Zylberberg, H.,, J. Jiang,, G. Pialoux,, F. Driss,, F. Carnot,, F. Dubois,, C. Brechot,, P. Berthelot,, and S. Pol. 1996. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients. Gastroenterol. Clin. Biol. 20:968971.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error